We have located links that may give you full text access.
Pap-test coverage in women aged 25 to 64 years old, according to the National Health Survey and the Surveillance System for Risk and Protective Factors for Chronic Diseases by Telephone Survey, 2013.
Brazilian Journal of Epidemiology 2018 August 28
OBJECTIVES: To estimate and describe the coverage of the Pap Smear test reported by women aged 25 to 64 years old from data collected by the National Health Survey (Pesquisa Nacional de Saúde - PNS) and to compare the estimates made by the Surveillance System for Risk and Protective Factors for Chronic Diseases using a Telephone Survey (Vigitel) for the same indicator in the Brazilian capital cities and the Federal District in 2013.
METHODS: Based on the data from the PNS and Vigitel, we estimated prevalence and 95% confidence intervals (95%CI) of women who reported having had a Pap test screening in the past 3 years.
RESULTS: According to the PNS, 79.4% (95%CI 78.5 - 80.2) of the women had had a cervical cancer screening in the past 3 years in Brazil. Women aged 55 to 64 years old (71.0%, 95%CI 68.7 - 73.3) and without an education or incomplete elementary school (72.1%, 95%CI 70.6 - 73.7) had the lowest prevalence, and 88.4% (95%CI 87.5 - 89.2) received test results within 3 months. There was no difference when comparing the estimates of the Vigitel with the PNS for the capital city and Federal District totals. In the PNS, the prevalence was 83.8% (95%CI 82.8 - 84.7) and in the Vigitel, it was 82.9% (95%CI 81.9 - 83.8). In addition, there were no differences by capital, except for Recife, Boa Vista, and João Pessoa.
CONCLUSION: Cervical cancer screening coverage for the target population is below the target of 85%. When comparing the data for the capital city and Federal District totals, we verified that the Vigitel System has been effective in monitoring this indicator, which is similar to PNS estimates.
METHODS: Based on the data from the PNS and Vigitel, we estimated prevalence and 95% confidence intervals (95%CI) of women who reported having had a Pap test screening in the past 3 years.
RESULTS: According to the PNS, 79.4% (95%CI 78.5 - 80.2) of the women had had a cervical cancer screening in the past 3 years in Brazil. Women aged 55 to 64 years old (71.0%, 95%CI 68.7 - 73.3) and without an education or incomplete elementary school (72.1%, 95%CI 70.6 - 73.7) had the lowest prevalence, and 88.4% (95%CI 87.5 - 89.2) received test results within 3 months. There was no difference when comparing the estimates of the Vigitel with the PNS for the capital city and Federal District totals. In the PNS, the prevalence was 83.8% (95%CI 82.8 - 84.7) and in the Vigitel, it was 82.9% (95%CI 81.9 - 83.8). In addition, there were no differences by capital, except for Recife, Boa Vista, and João Pessoa.
CONCLUSION: Cervical cancer screening coverage for the target population is below the target of 85%. When comparing the data for the capital city and Federal District totals, we verified that the Vigitel System has been effective in monitoring this indicator, which is similar to PNS estimates.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app